Skip to content

Clinical trials

Phase 2/3 Squamous Cell Carcinoma of Head and Neck trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 2/3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20131
20182
20192
20201
20213
20221
20231
20245
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting5
Completed5
Withdrawn2
Not yet recruiting2
Terminated2
Unknown status1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Shanghai Jiao Tong University School of Medicine2
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University2
All India Institute of Medical Sciences1
Bicara Therapeutics1
BioNTech SE1
Exelixis1
Gustave Roussy, Cancer Campus, Grand Paris1
Hookipa Biotech GmbH1
Inhibrx Biosciences, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck25
Head and Neck Neoplasms9
Mouth Neoplasms6
Laryngeal Neoplasms5
Oropharyngeal Neoplasms5
Hypopharyngeal Neoplasms4
Neoplasm Metastasis3
Recurrence3
Carcinoma2
Carcinoma, Squamous Cell2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.